Breast Lesion Localization Methods Market Exhibits Higher Growth Prospects during 2018-2026 | Key Players are Cook Medical Inc., Argon Medical Devices, Inc
Breast lesion localization methods are invasive or non-invasive techniques used to observe if lesions are palpable or non-palpable, as part of diagnosis of breast cancer. There are various types of breast lesion localization methods used globally to detect the abnormalities in terms of a lump or tumor in the breasts. Rampant increase in number of women opting for preventive screening tests for breast cancer creates a highly conducive environment for growth of the breast lesion localization methods market in the foreseeable future. Among various methods under breast lesion localization methods, radio occult localization lesion localization (ROLL) method is one of the fastest growing segments in terms of revenue share, which in turn is expected to underpin growth of the breast lesion localization methods market in the near future. ROLL is a precise method for early detection of breasts lesion, which includes three-dimensional localization of impalpable breast tumor in the body. It provides a unique advantage of high feasibility in connection with sentinel node biopsy in the same setting.
Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/104
Rapid strides made in technology and keen interest of healthcare providers to integrate cutting-edge solutions backed up by supportive government norms is fueling growth of this highly lucrative market, especially in developed regions. Furthermore, rise in prevalence of breast cancer globally, especially in Asia Pacific countries would inadvertently support market growth in the near future. In order to alleviate this spike in incidence rate of the malady, governments are focusing on strengthening the healthcare infrastructure through supportive regulatory norms and investments. Government and non-government organizations are actively focusing on developing awareness programs regarding breast cancer. Such initiatives are projected to bring about a rapid shift in market dynamics, with Asia Pacific taking on the mantle from North America to emerge as the largest market for breast lesion localization methods. According to The Economist Intelligence Unit Limited, in 2016, China had a comparatively low breast cancer burden by world standards, with 2012 age standardized ratio for incidence and mortality around 22.1 and 5.4 per 100,000 respectively. However, in India breast cancer incidence by global standards in 2012 age standardized ratio was around 25.8 per 100,000. Despite what the statistics tend to suggest, the extent of the disease has surged significantly unlike the steady rise as estimated earlier in 2009.
This report segments the global breast lesion localization methods market on the basis of technique, end user, and geography. On the basis of technique, the market is categorized into wire guided localization, radio guided occult lesion localization, radioactive seed localization, magnetic tracers and ultrasound guided surgery. The wire guided localization method is further divided into core biopsy needles and fine aspiration needles. On the basis of end user, the market is divided into hospitals, ambulatory and surgical centers, diagnostics centers, oncology centers and others. Among all end users, hospitals segment dominated the breast lesion localization methods market, owing to rapid advancements in medical systems.
Rising prevalence and increasing awareness about breast cancer is expected to be one of the primary factor for the growth of breast lesion localization methods market over the period
According to W.H.O, in 2012, breast cancer was the second-most prevalent cancer in the world and most frequent cancer among women, with an estimated around 1.7 Mn new cancer cases diagnosed in 2012. It is the most common cancer in women both in developed and emerging regions. Incidence rates are differ according to region, for instance, the incidence rate in Middle Africa 27 per 100,000 and 92 in Northern America. Furthermore, according to W.H.O, in 2012, breast cancer was the fifth prominent cause for mortality from cancer worldwide. In emerging economies, it is the second highest cause of cancer deaths. In developed regions, it led to around 198,000 deaths in 2012, accounting for 15.4% of all deaths related to cancer. This inadvertently is expected to favor growth of the breast lesion localization methods market in the near future. Furthermore, there has been study that a man also has a risk of developing a breast cancer in their whole life time, although the chances of the situation is mere 1 in 1,000, whereas in female it is around one in every eight women is susceptible for the growth of any type lesion. According to Breastcancer.org, in 2017, in the U.S. around 250,000 cases of invasive breast cancer are expected to be diagnosed along with over 60,000 cases of non-invasive breast cancer. This in turn creates a highly conducive environment for global breast lesion localization methods market in the near future.
Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/104
Large potential in untapped emerging economies is expected to fuel the growth in breast lesion localization methods market
Continuous rise in population in emerging economies such as India and increasing focus towards strengthening of the healthcare infrastructure in the region are expected to provide major growth traction for the breast lesion localization methods market in the near future. Furthermore, according to The Pink Initiative and Breast Cancer Statistics in India, in 2014, a significantly large population of patients below the age of 50 years suffered from breast cancer. The exact statistics represents that around 16% were in the age between 20 and 40 and 28% were in age between 40 and 50. Increasing awareness in such regions with high potential is expected to improve the time to market of highly effective and advanced products. The breast lesion localization methods market is expected to surge on a wave of renewed interest by healthcare providers and governments alike to tackle the menace of breast cancer in the not-so distant future.